Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa. - Wikidata - awgldk - TriplyDB

Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa.

Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa.

http://www.wikidata.org/entity/Q34310915

about

Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants Volatile metabolites of pathogens: a systematic review Assessment, origin, and implementation of breath volatile cancer markers.Detecting bacterial lung infections: in vivo evaluation of in vitro volatile fingerprints The use of colorimetric sensor arrays to discriminate between pathogenic bacteria Quantitative analysis of volatile organic compounds released and consumed by rat L6 skeletal muscle cells in vitro Exhaled breath profiling for diagnosing acute respiratory distress syndrome.Identification of Key Odorants in Used Disposable Absorbent Incontinence Products Breath gas metabolites and bacterial metagenomes from cystic fibrosis airways indicate active pH neutral 2,3-butanedione fermentation.Cellular scent of influenza virus infection.A translational approach to ventilator associated pneumonia.Product ion distributions for the reactions of NO(+) with some physiologically significant volatile organosulfur and organoselenium compounds obtained using a selective reagent ionization time-of-flight mass spectrometer.Development of models for predicting the predominant taste and odor compounds in Taihu Lake, China.Microbial volatile emissions as insect semiochemicals.Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitro.Analysis of volatile organic compounds liberated and metabolised by human umbilical vein endothelial cells (HUVEC) in vitro.Collagen and hyaluronan at wound sites influence early polymicrobial biofilm adhesive events.Novel Essential Role of Ethanol Oxidation Genes at Low Temperature Revealed by Transcriptome Analysis in the Antarctic Bacterium Pseudomonas extremaustralis.Unbiased profiling of volatile organic compounds in the headspace of Allium plants using an in-tube extraction device.A Compendium of Volatile Organic Compounds (VOCs) Released By Human Cell Lines.Assessment of the exhalation kinetics of volatile cancer biomarkers based on their physicochemical properties Updated approach for the assessment of ventilator-associated pneumonia.Detection of volatile malodorous compounds in breath: current analytical techniques and implications in human disease.Volatile Compounds Produced by Lactobacillus paracasei During Oat Fermentation.Volatile organic compound detection as a potential means of diagnosing cutaneous wound infections.Mass spectrometric techniques for the analysis of volatile organic compounds emitted from bacteria.Comparative analysis of the volatile metabolomes of Pseudomonas aeruginosa clinical isolates.The human bitter taste receptor T2R38 is broadly tuned for bacterial compounds.Volatile organic compounds in ventilated critical care patients: a systematic evaluation of cofactors.A rapid method for breath analysis in cystic fibrosis patients.Ethanolamine Catabolism in Pseudomonas aeruginosa PAO1 Is Regulated by the Enhancer-Binding Protein EatR (PA4021) and the Alternative Sigma Factor RpoN.Rational lung tissue and animal models for rapid breath tests to determine pneumonia and pathogens.Characteristics of volatile organic compounds produced from five pathogenic bacteria by headspace-solid phase micro-extraction/gas chromatography-mass spectrometry.Comprehensive volatile metabolic fingerprinting of bacterial and fungal pathogen groups.Initial study of three different pathogenic microorganisms by gas chromatography-mass spectrometry.Volatile molecules from bronchoalveolar lavage fluid can 'rule-in' Pseudomonas aeruginosa and 'rule-out' Staphylococcus aureus infections in cystic fibrosis patients.Mass spectrometry-based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders.Direct Growth of Bacteria in Headspace Vials Allows for Screening of Volatiles by Gas Chromatography Mass Spectrometry.Volatile fingerprinting of <i>pseudomonas aeruginosa</i> and respiratory syncytial virus infection in an <i>in vitro</i> cystic fibrosis co-infection model.Investigation of volatile metabolites during growth of Escherichia coli and Pseudomonas aeruginosa by needle trap-GC-MS.

P2860

Q24817107-E2409624-3442-4651-8ADF-E1354F12C8CD Q27001726-FF3C2CB5-9A73-4F43-B6BA-97316BC654A4 Q27692565-B5EFC98F-A0E7-4CFC-8439-EE25642E197C Q28283051-DAE8D16D-47DF-446C-9CA6-31201569AC64 Q28487898-87FD1B3D-4C91-480B-8D6C-336C98AFF2D1 Q28601030-FE4409C8-E28A-4700-A39F-83F7AAA3DCFF Q33613793-F912D9B6-5994-4B14-B224-6674C83A0FAA Q33637806-EC9A62D8-1473-47B5-B483-C5CB245D52B2 Q33647129-600BD9D0-6B95-4B12-9A22-9019CBC3DA5E Q33923347-922A4A80-D47F-4140-918A-DD42D57D3F25 Q33985790-3F0BA1C8-5F47-4956-B053-C2F0525DAED7 Q34079351-2A21B3D0-72A6-4280-852B-1791D90BCF7B Q34532653-DED18AF8-A3CB-41A2-9E97-542D7E94CE7E Q34781744-CE1783DB-515E-4D3D-A0E5-C6170D46888B Q34840709-840143D0-20D6-4A08-8D72-839949081AE4 Q34900602-E8E2CD4A-025C-437D-9FFF-25F59E24104C Q35207214-E82ABD74-F1A4-46DF-BAA3-11CBF6C53A1B Q35869773-E2B1CCBD-66DE-49C3-B74E-04FF8E9E8AB8 Q35940353-A91CD37F-02B5-4C71-BCF6-ACDEBA40DD8C Q36012613-F333D1E4-C84C-43A5-BD8B-F0D0736BC6EB Q37138493-DBBDC5E9-9F1F-43FA-B105-955432A769B2 Q37308799-8DCD52DD-411B-4E74-98DC-A5B87F24253D Q38182688-8AFC585E-4C83-4487-8FA0-042E33FB7744 Q39124584-299B707A-6AAD-4326-B28C-B56064C65336 Q39447497-D8E81FDC-6B45-4BF2-88B1-DB588B25F2D7 Q39454020-1CC2C324-A50A-47DB-B418-200BA3C3CAF9 Q40442905-BFD5C4B8-1D7B-4208-AA53-3DC127F8D843 Q41144519-3ED8807B-B192-428B-9C41-E32092696BA7 Q41492819-CCE0939E-02CA-435D-B3A6-DA4094F18A88 Q41644928-F1539CD5-157B-4EE3-8E1C-166EDF63C1D0 Q41819527-62EAD361-4749-4DAF-9669-163DB921A9A7 Q46127852-F59ABB75-8FE8-4CD6-B464-266CDCEA2F46 Q46456125-CF56D48C-668E-4894-BB9A-B3FB7AC5AA91 Q47626949-50C1B9CB-1A93-4EB6-8522-247F12EBF968 Q47640652-A5C6C713-9DD4-4827-8A0B-6DDF5293384D Q47655373-A00E8776-8BFF-45F0-8A5D-7E902B731ACB Q47972723-DA671302-0F72-4B44-9DCC-6454EBE03336 Q53409127-93475791-4DF2-4032-A2C2-F76F436384A1 Q54218839-1FCF49A3-26FA-4A85-9664-35A58C2FCCE0 Q54283398-AF382318-DCEE-43D1-8B4E-0E5567CA284F

P2860

Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa.

http://www.wikidata.org/entity/Q34310915

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Molecular analysis of volatile ...... us and Pseudomonas aeruginosa.

@ast

Molecular analysis of volatile ...... us and Pseudomonas aeruginosa.

@en

Molecular analysis of volatile ...... us and Pseudomonas aeruginosa.

@nl

type

label

Molecular analysis of volatile ...... us and Pseudomonas aeruginosa.

@ast

Molecular analysis of volatile ...... us and Pseudomonas aeruginosa.

@en

Molecular analysis of volatile ...... us and Pseudomonas aeruginosa.

@nl

prefLabel

Molecular analysis of volatile ...... us and Pseudomonas aeruginosa.

@ast

Molecular analysis of volatile ...... us and Pseudomonas aeruginosa.

@en

Molecular analysis of volatile ...... us and Pseudomonas aeruginosa.

@nl

P1433

Q34310915-EE584471-E879-42B2-90B1-773C46377513

P1476

Q34310915-643AC694-C62F-40E8-8F64-250234AA74C7

P2093

Q34310915-0CCF9A20-AE7E-4D45-8F8B-063D62788922

Q34310915-2534D9C2-74AC-44F3-9D2D-F043298F586E

Q34310915-8C693EBC-3C2E-4404-8CE8-BC47D498A3F9

Q34310915-AC38D7AF-6C2D-44AB-8395-FE1DB82349F2

Q34310915-DF3537CC-C681-4207-BC23-90B7AA0211DF

Q34310915-EB33E7D1-8C94-4E41-A7B1-9E3AAA2EBE93

Q34310915-EDD10E1A-E7E0-4E26-A2B9-7AB849DA412D

Q34310915-F3E70556-E54E-4DAC-AF3E-9A5CC2AE2C8A

P2860

Q34310915-01002575-282B-4CD4-8CDD-54731FB3B0ED

Q34310915-06F57233-8918-426E-BF8F-7DC5513B1FF4

Q34310915-103DBAF1-CC6B-43A0-94EC-0325874AE32B

Q34310915-1306F93D-006B-4594-A994-C700CC2482A5

Q34310915-138E0477-5589-44A8-B505-D89B16D1B16C

Q34310915-1447B1F0-836F-4FB2-A762-5898CE0B50F3

Q34310915-1CF54F92-F7A8-4B40-979D-DBCD5B471142

Q34310915-1E18B5F0-66EB-4C00-9ACC-7AE6CA101A20

Q34310915-4A98B9C2-3DE1-415A-9466-EC879908ECE8

Q34310915-549BC214-B4FA-4081-A61D-36E7BD97C6D3

P2888

Q34310915-EC990D8E-2DF3-4FC1-895E-3BFC7831D828

P304

Q34310915-6094B051-2D19-43C6-871C-09FEA248E8A2

P31

Q34310915-95C33A15-A5EE-4887-99CB-6503C9082C56

P356

Q34310915-4A3CFD9C-AC9E-430D-B807-0D2A53791829

P478

Q34310915-AA831DF2-17A1-41C0-B860-8FBC9ECBA71C

P50

Q34310915-3ADF96F7-17FB-43D8-B958-B5A021CD1AEF

P577

Q34310915-BE458A55-6D9C-426E-B477-F1E496465827

P5875

Q34310915-4A6C9326-E30E-4D63-B80E-425ADE8A37C7

P6179

Q34310915-3ED97052-CC06-4896-A99C-EA8C948784FC

P698

Q34310915-8418AA55-80A1-48A9-87B3-F3D8730D0E7D

P921

Q34310915-57E52CCA-098E-4105-A355-166E6E05CD24

P932

Q34310915-61058D18-B74E-4DD5-8B87-DCEBB7ACC984

P356

1471-2180-12-113

P1433

BMC Microbiology

P1476

Molecular analysis of volatile ...... eus and Pseudomonas aeruginosa

@en

P2093

Andreas Sponring

http://www.w3.org/2001/XMLSchema#string

Anna Filipiak

http://www.w3.org/2001/XMLSchema#string

Anton Amann

http://www.w3.org/2001/XMLSchema#string

Clemens Ager

http://www.w3.org/2001/XMLSchema#string

Helmut Wiesenhofer

http://www.w3.org/2001/XMLSchema#string

Jakob Troppmair

http://www.w3.org/2001/XMLSchema#string

Maria Magdalena Baur

http://www.w3.org/2001/XMLSchema#string

Wojciech Filipiak

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units

Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro.

Noninvasive detection of lung cancer by analysis of exhaled breath.

2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung.

Detoxification of hydrogen sulfide and methanethiol in the cecal mucosa.

Diversity of L-methionine catabolism pathways in cheese-ripening bacteria

Measurement and biological significance of the volatile sulfur compounds hydrogen sulfide, methanethiol and dimethyl sulfide in various biological matrices.

Elucidation of the methylerythritol phosphate pathway for isoprenoid biosynthesis in bacteria and plastids. A metabolic milestone achieved through genomics.

Pathophysiology and management of pulmonary infections in cystic fibrosis.

P2888

1471-2180-12-113

P304

113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2180-12-113

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227707948

http://www.w3.org/2001/XMLSchema#string

P6179

1041709480

http://www.w3.org/2001/XMLSchema#string

P698

22716902

http://www.w3.org/2001/XMLSchema#string

P921

Pseudomonas aeruginosa

P932

3444334

http://www.w3.org/2001/XMLSchema#string